Literature DB >> 27900019

The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer.

Christian Ostheimer1, Franziska Schweyer1, Thomas Reese1, Matthias Bache1, Dirk Vordermark1.   

Abstract

The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.

Entities:  

Keywords:  NSCLC; osteopontin; prognostic factors; radiotherapy; tumor volume

Year:  2016        PMID: 27900019      PMCID: PMC5103967          DOI: 10.3892/ol.2016.5104

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume.

Authors:  Kiyoshi Basaki; Yoshinao Abe; Masahiko Aoki; Hidehiro Kondo; Yoshiomi Hatayama; Shigeyuki Nakaji
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-13       Impact factor: 7.038

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

Review 3.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

4.  Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control.

Authors:  Daniel Zips; Simon Böke; Theresa Kroeber; Andreas Meinzer; Kerstin Brüchner; Howard D Thames; Michael Baumann; Ala Yaromina
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

5.  Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer.

Authors:  T Wigren
Journal:  Radiother Oncol       Date:  1997-07       Impact factor: 6.280

6.  Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.

Authors:  Quynh-Thu Le; Christina Kong; Phillip W Lavori; Ken O'byrne; Janine T Erler; Xin Huang; Yijun Chen; Hongbin Cao; Robert Tibshirani; Nic Denko; Amato J Giaccia; Albert C Koong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-01       Impact factor: 7.038

7.  Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.

Authors:  Maria Werner-Wasik; R Suzanne Swann; Jeffrey Bradley; Mary Graham; Bahman Emami; James Purdy; William Sause
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor.

Authors:  Yuki Yamane; Genichiro Ishii; Koichi Goto; Motohiro Kojima; Masayuki Nakao; Yoshihisa Shimada; Yutaka Nishiwaki; Kanji Nagai; Hirotsugu Kohrogi; Atsushi Ochiai
Journal:  J Thorac Oncol       Date:  2010-01       Impact factor: 15.609

10.  The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy.

Authors:  Tae Ryool Koo; Sung Ho Moon; Yu Jin Lim; Ja Young Kim; Yeonjoo Kim; Tae Hyun Kim; Kwan Ho Cho; Ji-Youn Han; Young Joo Lee; Tak Yun; Heung Tae Kim; Jin Soo Lee
Journal:  Radiat Oncol       Date:  2014-12-13       Impact factor: 3.481

View more
  6 in total

Review 1.  Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.

Authors:  Lukas Käsmann; Maximilian Niyazi; Oliver Blanck; Christian Baues; René Baumann; Sophie Dobiasch; Chukwuka Eze; Daniel Fleischmann; Tobias Gauer; Frank A Giordano; Yvonne Goy; Jan Hausmann; Christoph Henkenberens; David Kaul; Lisa Klook; David Krug; Matthias Mäurer; Cédric M Panje; Johannes Rosenbrock; Lisa Sautter; Daniela Schmitt; Christoph Süß; Alexander H Thieme; Maike Trommer-Nestler; Sonia Ziegler; Nadja Ebert; Daniel Medenwald; Christian Ostheimer
Journal:  Strahlenther Onkol       Date:  2017-10-13       Impact factor: 3.621

2.  Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?

Authors:  Khaled Elsayad; Laith Samhouri; Sergiu Scobioala; Uwe Haverkamp; Hans Theodor Eich
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-05       Impact factor: 4.553

Review 3.  Osteopontin as a biomarker for osteosarcoma therapy and prognosis.

Authors:  Xingwen Han; Wenji Wang; Jingjing He; Lei Jiang; Xun Li
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

4.  Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group.

Authors:  C Ostheimer; M Mäurer; N Ebert; D Schmitt; D Krug; R Baumann; C Henkenberens; F A Giordano; L Sautter; Guerra López; D F Fleischmann; M Niyazi; L Käsmann; D Kaul; A H Thieme; C Billiet; S Dobiasch; C R Arnold; M Oertel; J Haussmann; T Gauer; Y Goy; C Suess; S Ziegler; C M Panje; C Baues; M Trommer; T Skripcak; D Medenwald
Journal:  Strahlenther Onkol       Date:  2021-01-07       Impact factor: 3.621

5.  Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis through the PI3K Pathway : Osteopontin Regulates Endometrial Cell Migration in Endometriosis.

Authors:  Xiaoxia Fu; Mengyun Yao; Chaoshuang Ye; Tao Fang; Ruijin Wu
Journal:  Reprod Sci       Date:  2020-09-09       Impact factor: 3.060

6.  The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation.

Authors:  Alexander Rühle; Anca-L Grosu; Nicole Wiedenmann; Juri Ruf; Birgit Bieber; Raluca Stoian; Andreas R Thomsen; Eleni Gkika; Peter Vaupel; Dimos Baltas; Wolfgang A Weber; Michael Mix; Nils H Nicolay
Journal:  Clin Transl Radiat Oncol       Date:  2022-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.